Chronic Leukemia Perspective

• Targeted Therapy for CLL: Beyond Chemotherapy: New Targeted Agents   Many targeted therapies have improved outcomes over chemotherapy for CLL. BTK inhibition, BCL-2 inhibitors, and monoclonal antibodies are discussed.
  Medscape TV, February 13, 2020
• CLL Highlights From ASH 2019   Dr William Wierda of MD Anderson Cancer Center reviews key studies on chronic lymphocytic leukemia therapies presented at the 2019 American Society of Hematology (ASH) meeting in Orlando, Florida.
  Medscape, January 06, 2020
• The 8 Most Notable Cancer Clinical Trials of 2019 Expert oncologists share the trials most likely to change your approach to patient care going forward.
  Medscape Oncology, December 13, 2019
• Emerging Trends: Targeted Therapy for CLL: FISHing for Risk Markers   The molecular profile of the disease is a crucial prognostic indicator in CLL. Oncologists discuss markers to distinguish low-risk from high-risk disease.
  Medscape TV, December 12, 2019
• Chronic Lymphocytic Leukemia: 5 Things to Know The most common adult leukemia has seen a rush of new evidence in recent years. Here are some of the highlights.
  Medscape Oncology, September 24, 2019
• Emerging Trends: Targeted Therapy for CLL   MD Anderson hematologists discuss recent developments in treatment options for chronic lymphocytic leukemia, including monoclonal antibodies, targeted therapies, and small-molecule inhibitors.
  Medscape TV, September 16, 2019
• EHA 2019 Read clinically focused news coverage of key developments from EHA 2019
  Medscape Oncology, June 10, 2019
• BSH 2019 Read clinically focused news coverage of key developments from BSH 2019
  Medscape Oncology, April 01, 2019
• CAR T Cell Therapy: 'It's the Real World Now'   Drs Jacobson, Miklos, and Maus unveil 'provocative and exciting' research at ASH 2018 in CAR T cell therapy.
  Medscape Oncology, January 24, 2019
• Venetoclax Shows Benefits Across a Range of Hematologic Cancers   From ASH 2018, Ann LaCasce and Jennifer Crombie from Dana-Farber discuss new trial data on venetoclax, a potent, selective inhibitor of BCL2.
  Medscape Oncology, December 27, 2018
• Top News From ASH 2018: Slideshow Hot topics include practice change data on chronic lymphocytic leukemia, validation of the durability of CAR T cells, and a new standard of care in myeloma.
  Medscape News Slideshows, December 17, 2018
• Chronic Myeloid Leukemia: Stopping Therapy the Right Way   The MD Anderson team discusses ways to increase patient compliance with TKI therapy as well as the correct way to stop TKI therapy electively for years at a time.
  Medscape TV, November 09, 2018
• Time Out! A Close Look at Antibiotic Use in LTC Clinical cases illustrate the overuse of antibiotics to treat radiographic findings and lab reports, especially when prescribing over the phone.
  Medscape Infectious Diseases, October 02, 2018
• Chronic Myeloid Leukemia: Critical Questions   The choice of first-, second-, and third-generation TKIs, with their varying toxicity profiles, and uncertainties about generic imatinib complicate frontline therapy.
  Medscape TV, September 12, 2018
• EHA 2018 Read clinically focused news coverage of key developments from EHA 2018
  Medscape Oncology, June 15, 2018
• Chronic Myeloid Leukemia: Rewriting Frontline Therapy   For 20 years, TKIs have been standard treatment in CML. But a growing number of options, including generic imatinib, raises questions regarding what is optimal frontline therapy for a given patient.
  Medscape TV, June 13, 2018
• A 71-Year-Old Man With Malaise: USMLE Question A 71-year-old man presents with fatigue and malaise over the past three months. He also reports a 10 lbs weight loss. What's causing these symptoms?
  Osmosis, May 25, 2018
• A 70-Year-Old Man With Splenomegaly: USMLE Question A 70-year-old man presents with splenomegaly. What is most likely to be found upon staining his cells?
  Osmosis, April 20, 2018
• Maximizing Response in Acute Leukemia: Pearls From ASH 2017   Drs Cortes and DeAngelo highlight the most intriguing clinical trials presented in the field of leukemia at ASH 2017.
  Medscape Oncology, January 29, 2018
• With So Many Options, Best CLL Treatment May Be a Clinical Trial Combination regimens in CLL are already impressive, but new combinations currently being evaluated have strong potential to be even better.
  Medscape Oncology, January 18, 2018